LOVFF (Cannara Biotech) Beta : 0.47 (As of Dec. 15, 2024)

Cannara Biotech Beta Chart

Cannara Biotech Quarterly Data
	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24	Aug24
Beta	Get a 7-Day Free Trial															0.83	0.52	0.55	0.56	0.51

Competitive Comparison of Cannara Biotech's Beta

For the Drug Manufacturers - Specialty & Generic subindustry, Cannara Biotech's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cannara Biotech's Beta Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cannara Biotech's Beta distribution charts can be found below:

* The bar in red indicates where Cannara Biotech's Beta falls into.

Cannara Biotech Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Cannara Biotech  (OTCPK:LOVFF) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)

Cannara Biotech Beta Related Terms

Thank you for viewing the detailed overview of Cannara Biotech's Beta provided by GuruFocus.com. Please click on the following links to see related term pages.

Cannara Biotech Business Description